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Background. Recent studies have provided strong evidence that variation in the gene neurocan (NCAN, rs1064395) is a
common risk factor for bipolar disorder (BD) and schizophrenia. However, the possible relevance of NCAN variation to
disease mechanisms in the human brain has not yet been explored. Thus, to identify a putative pathomechanism, we
tested whether the risk allele has an inﬂuence on cortical thickness and folding in a well-characterized sample of patients
with schizophrenia and healthy controls.
Method. Sixty-three patients and 65 controls underwent T1-weighted magnetic resonance imaging (MRI) and were
genotyped for the single nucleotide polymorphism (SNP) rs1064395. Folding and thickness were analysed on a node-
by-node basis using a surface-based approach (FreeSurfer).
Results. In patients, NCAN risk status (deﬁned by AA and AG carriers) was found to be associated with higher folding
in the right lateral occipital region and at a trend level for the left dorsolateral prefrontal cortex. Controls did not show
any association (p>0.05). For cortical thickness, there was no signiﬁcant effect in either patients or controls.
Conclusions. This study is the ﬁrst to describe an effect of the NCAN risk variant on brain structure. Our data show that
the NCAN risk allele inﬂuences cortical folding in the occipital and prefrontal cortex, which may establish disease
susceptibility during neurodevelopment. The ﬁndings suggest that NCAN is involved in visual processing and top-
down cognitive functioning. Both major cognitive processes are known to be disturbed in schizophrenia. Moreover,
our study reveals new evidence for a speciﬁc genetic inﬂuence on local cortical folding in schizophrenia.
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Introduction
Schizophrenia is a severe mental illness that affects 1%
of the population worldwide. Among the major psy-
chiatric disorders, schizophrenia shows one of the
highest estimates of heritability, ranging between 60%
and 90% (Nöthen et al. 2010). However, the neuro-
biological abnormalities determined by this genetic
risk are poorly understood. In a recent genome-wide
association study (GWAS) and in a follow-up study
(Cichon et al. 2011), we found strong statistical evi-
dence that the single nucleotide polymorphism (SNP)
rs1064395 in the 3′ untranslated region of the neurocan
(NCAN) gene on chromosome 19p13.11 is a risk factor
for bipolar disorder (BD). In view of formal genetic
and molecular genetic evidence that BD and schizo-
phrenia share some of their risk factors, we performed
a subsequent association study and identiﬁed that this
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common variation is also a risk factor for schizo-
phrenia (Mühleisen et al. 2012). Both studies found
that the A allele of rs1064395 is the risk-mediating
allele. These results suggest that the SNP rs1064395
inﬂuences risk to a broader psychosis phenotype. In
the next step, imaging studies are necessary to test
the hypothesis that the NCAN risk allele mediates
pathophysiologically relevant changes in the brain.
NCAN, formerly termed CSPG3, encodes neurocan,
a brain-speciﬁc chondroitin sulfate proteoglycan
(CSPG) of the lectican family (Prange et al. 1998).
Recent analyses of mRNA expression patterns in
mice and humans suggest an important role for
NCAN in the developing mammalian brain (Cichon
et al. 2011; see also BrainSpan: Atlas of the Developing
Human Brain; www.brainspan.org). Neurocan mol-
ecules are mainly expressed by reactive astrocytes, but
also by neurons (Karetko & Skangiel-Kramska, 2009).
Neurocan interacts with cell surface molecules, such
as neural cell adhesion molecule (NCAM), L1/neuron-
glia (L1/Ng)-CAM, transient axonal glycoprotein-1
(TAG-1)/axonin-1 and an N-cadherin-binding N-acetyl-
galactosaminyl phosphoryltransferase (GalNAcPTase)
(Rauch et al. 2001). These features enable neurocan to
participate in the modulation of cell adhesion and
migration. Furthermore, neurocan and other lecticans
are thought of as ‘organizers’ of the extracellular
matrix (ECM) in the central nervous system (Yamagu-
chi, 2000). From embryogenesis to early postnatal
stages, neurocan is one of the predominant lecticans
in the brain ECM whereas, later in life, other mem-
bers of this protein family prevail (Frischknecht &
Seidenbecher, 2008; Karetko & Skangiel-Kramska,
2009). Characterization of NCAN double-knockout
mice demonstrated impaired pre-pulse inhibition
(Miró et al. 2012), an intermediate phenotype for schizo-
phrenia and also for BD (Thaker, 2008). The affected
mice also showed higher exploratory and overall loco-
motor activity. Accordingly, in patients with schizo-
phrenia and BD, the risk allele was strongly associated
with the symptom dimension overactivity, providing
further support for an association between NCAN and
psychosis pathophysiology (Miró et al. 2012). Despite
these strong molecular and behavioural data, the poss-
ible relevance of NCAN variation for disease mechan-
isms in the human brain has not yet been explored.
In the past few years, imaging genetics has emerged
as a promising approach in neuropsychiatric research.
It enables identiﬁcation and characterization of genetic
variants that inﬂuence brain structure and function
underlying normal and abnormal biological pathways
(Esslinger et al. 2009; Erk et al. 2010; Schultz et al. 2011;
Stein et al. 2012). In the present study, we investi-
gated the SNP rs1064395 for a potential effect on cor-
tical morphology using a clinically well-characterized
sample of 63 patients with a DSM-IV diagnosis of
schizophrenia and 65 healthy controls, all of German
origin. We measured two parameters for cortical
shape (cortical thickness and cortical folding) and sub-
divided the patients and controls according to their
NCAN risk status. Cortical thickness is assumed to ap-
proximate the distance between the pial surface (outer
surface) and the border between the grey and white
matter (inner surface) of the cortex. As major parts of
the formation of gyri (and sulci) take place in the third
prenatal trimester (White & Hilgetag, 2011), cortical
folding can be regarded as a sensitive marker for aber-
rations in neurodevelopment. Alterations in cortical
thickness (Kuperberg et al. 2003; Narr et al. 2005a,b;
Fornito et al. 2008; Nesvåg et al. 2008; Schultz et al.
2010b,c) and cortical folding (McIntosh et al. 2009;
Schultz et al. 2010a; Palaniyappan et al. 2011) have
been associated repeatedly with schizophrenia. Ad-
ditionally, both structural measures are highly heritable
(Rogers et al. 2010; Winkler et al. 2010) and are therefore
suitable intermediate phenotypes for our approach.
Carrying the minor allele A of rs1064395 has been
shown to confer a risk effect that increases disease sus-
ceptibility and, conversely, carrying the G-allele can be
assumed to establish a protective effect (Cichon et al.
2011; Mühleisen et al. 2012). We therefore hypoth-
esized that carriers of the genotypes AA and AG exhi-
bit aberrant cortical thickness and/or cortical folding
in comparison to carriers of the genotype GG.
Method
Subjects
We studied 63 patients with schizophrenia and 65 con-
trols. All participants were right-handed (Annett,
1967). Diagnoses based on the SCID were established
by a clinical psychiatrist (I.N.) and conﬁrmed by two
independent psychiatrists (R.G.M.S. and C.C.S.). All
patients met DSM-IV criteria for schizophrenia and
had no second psychiatric diagnosis. Of the 63 patients,
58 were diagnosed as paranoid, two as undifferen-
tiated, two as disorganized and one as catatonic sub-
type of schizophrenia according to DSM-IV. They
were on stable medication, mostly with second-
generation antipsychotics.
Healthy controls were screened for major medical,
neurological and psychiatric history. None of the con-
trols had a current psychiatric disorder, or a history
of psychiatric disorder, and none had ﬁrst-degree rela-
tives with a psychiatric disorder according to DSM-IV.
Exclusion criteria for all participants were neurological
disease or damage, or medical disorders potentially
inﬂuencing neurocognitive function. Ancestry was
assigned to patients and controls on the basis of
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self-reported ancestry. All participants were of German
origin. None of the subjects were consanguineous. All
participants gave written informed consent to the
study, which was approved by the Ethics Committee
of Friedrich-Schiller University. Sociodemographic
and psychopathological data are given in Table 1.
Magnetic resonance imaging (MRI)
MRI acquisition
We acquired high-resolution anatomical T1-weighted
MRI scans in a 1.5-T Siemens Magnetom Vision
whole-body system (Erlangen, Germany) using a
three-dimensional spoiled gradient echo sequence:
1-mm-thick sagittal slices with repetition time (TR)=
15ms, echo time (TE)=5ms, ﬂip angle=30°, ﬁeld
of view (FOV)=256mm×256mm, matrix=256×256,
number of sagittal slices=192. All scans were inspected
for motion artefacts and a neuroradiologist conﬁrmed
the absence of gross pathological ﬁndings.
MR scan processing and calculation of cortical shape
measures
We used the FreeSurfer software package (version
4.0.5; http://surfer.nmr.mgh.harvard.edu; Dale et al.
1999; Fischl et al. 1999) for image processing and for
thickness and folding analyses. Image processing com-
prised the removal of non-brain tissue, transformation
to Talairach-like space and segmentation of grey/white
matter tissue. The white/grey matter boundary was
tessellated and topological defects were corrected auto-
matically. After intensity normalization, transition of
the grey/white matter and pial boundary was ident-
iﬁed by detecting the greatest shift in intensity through
surface deformation. The entire cortex of each partici-
pant was then inspected visually and any inaccuracies
in segmentation were edited manually.
Computation of cortical thickness
Cortical thickness was computed by ﬁnding the short-
est distance between a given point (node of vertices) on
the estimated pial surface and the grey/white matter
boundary and vice versa and averaging these two
values (Fischl & Dale, 2000). As the cortical maps gen-
erated were not restricted to the voxel resolution of
the original data, they were capable of detecting sub-
millimetre differences between diagnostic groups.
This automated approach of cortical thickness measure-
ment has been validated against manual measure-
ments in schizophrenia (Kuperberg et al. 2003).
Computation of cortical folding
Absolute mean curvature represents a very reliable
local measure for cortical folding alterations, allowing
a ﬁne-grained comparison of cortical folding covering
the entire cortex (Gaser et al. 2006; Luders et al. 2006).
Absolute mean curvature of the pial surface was cal-
culated as described by Schultz et al. (2010a) for
approximately 150000 nodes in each hemisphere of
the brain.
Genotyping and determination of subgroups
according to the risk status
For the patients, rs1064395 genotypes were extracted
from a genome-wide data set that had been geno-
typed and quality controlled in the study by
Rietschel et al. (2011). For the controls, lymphocyte
DNA was isolated from venous blood samples using
standard methods. To target SNP rs1064395 a primer
pair was designed. Amplicons were generated using
standard polymerase chain reaction (PCR) conditions.
These were then sequenced using the Sanger method
and a 3130XL Genetic Analyzer (Applied Biosystems,
USA). Electropherograms were analysed by two inde-
pendent investigators using SeqMan II (DNAStar,
USA).
Depending on the NCAN risk status, patients and
controls were divided into subgroups resulting in
Table 1. Demographic and clinical data
Genetic groups
pGG AA/AG
Healthy controls
n 51 14
Age (years), mean (S.D.) 26.7 (6.8) 25.6 (8.1) 0.593
Patients
n 49 14
Age (years), mean (S.D.) 29.4 (10.0) 26.9 (10.0) 0.410
PANSS total, mean (S.D.) 69.2 (26.5) 73.9 (28.7) 0.565
PANSS positive,
mean (S.D.)
15.8 (7.3) 19.3 (8.3) 0.150
PANSS negative,
mean (S.D.)
18.1 (6.9) 17.4 (10.2) 0.788
CPZE, mean (S.D.) 479.8 (419.1) 283.3 (208.1) 0.122
PANSS, Positive and Negative Syndrome Scale (Kay et al.
1987); CPZE, chlorpromazine equivalents; S.D., standard
deviation.
Participants were grouped according to their NCAN risk
status, that is homozygous and heterozygous risk genotype
(AA+AG) versus the homozygous non-risk genotype (GG)
of the single nucleotide polymorphism (SNP) rs1064395.
There were no signiﬁcant differences with regard to age
and gender between the resulting genotype groups
(p values>0.190).
p values resulting from a two-sample t test.
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two genotype groups for each diagnostic group, that is
2× (AA+AG) and 2×GG, for statistical analyses. We
compared risk allele (A) carriers with non-risk allele
carriers in patients and controls separately, that is con-
trols: AA+AG versus GG; patients: AA+AG versus GG.
There were no signiﬁcant differences with regard to
age and gender between the resulting genotype groups
(p values>0.190).
Statistical analyses
Statistical cortical maps
Cortical thickness and cortical folding measurements
at each vertex of the subjects’ surface were mapped
onto a common spherical coordinate system using a
spherical transformation. Maps were smoothed using
a Gaussian kernel of 10mm. A general linear model
(GLM) controlling for the effect of age was used to esti-
mate differences in cortical thickness and cortical fold-
ing at each node. The GLM is based on an ANCOVA
approach. Right and left hemispheres were tested
separately.
Monte Carlo simulation and clustering
For correction of multiple comparisons, a Monte Carlo
simulation (10000 iterations) and a cluster analysis
were performed to identify contiguous clusters of
signiﬁcant cortical thickness and cortical folding differ-
ences between the two genotype groups for each
analysis (p<0.05). The simulation and clustering ap-
proach is based on the AlphaSim algorithm (Ward,
2000).
Results
Effect of NCAN risk status on the two cortical
shape measures
Schizophrenia patients carrying the homozygous and
heterozygous risk genotypes (AA, AG) exhibited
signiﬁcantly higher cortical folding covering parts
of the right visual cortex (V1 and V2 areas) than
patients with the GG genotype (CWP=0.032; Table 2,
Fig. 1 b). A statistical trend (CWP=0.073) was found
for the left dorsolateral prefrontal cortical folding in
the schizophrenia risk carriers (Table 2; Fig. 1a). Extrac-
tion of the cortical folding values from these clusters
demonstrated comparable highly signiﬁcant nominal
p values: p=1×10−4 for the lateral occipital cluster
and p=6.10×10−5 for the prefrontal cluster.
No effect of NCAN risk status on cortical folding was
observed in the controls. For cortical thickness, no
effect of the risk variant was found, either in the
patients or in the controls.
Genotype×diagnosis interaction
To test for differing effects of the rs1064395 genotype
on diagnosis, we additionally performed a genotype×
diagnosis interaction analysis as in prior imaging gen-
etics studies (Prata et al. 2009), using the same statisti-
cal parameters as deﬁned for the initial analyses
(Monte Carlo simulation, clustering). We found a sig-
niﬁcant genotype×diagnosis interaction for cortical
folding in the right superior parietal cortex, that is
the inﬂuence of the NCAN variant on cortical folding
was signiﬁcantly stronger in patients (in the direction
of a higher cortical folding in risk carriers) than in
controls.
Comparison of cortical thickness and folding
between patients and controls
We analysed the main effect of diagnosis on cortical
thickness and folding post hoc using the same statistical
conditions as deﬁned for the primary analyses. Pa-
tients showed signiﬁcant cortical thinning in several
cortical areas including the left superior, middle and
inferior temporal cortex, left inferior parietal, right
inferior frontal, orbitofrontal, right superior, middle
and inferior temporal cortex, in line with previous
Table 2. Results of the cluster analysis for cortical folding in patients with schizophrenia
Cortex area Size (mm2)
Talairach coordinates
CWP p value (nominal)x y z
Right lateral occipital 623.1 25.3 −95.0 3.6 0.032 1.00×10−4
Left dorsolateral prefrontal 526.4 −7.1 24.4 52.9 0.073 6.10×10−5
CWP, Cluster-wise probability.
CWP (corrected for multiple testing) resulting from the cluster analysis in each cortical hemisphere; nominal (uncorrected)
p values resulting from Student’s t tests comparing the average cortical folding values at the identiﬁed anatomical clusters
(as illustrated in Fig. 1).
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ﬁndings (Kuperberg et al. 2003; Narr et al. 2005a,b;
Nesvåg et al. 2008; Schultz et al. 2010b,c). We found
no signiﬁcant cortical folding differences between
patients and controls.
In a subsequent analysis, we compared cortical
thickness and folding only in risk allele carriers using
the same statistical parameters as deﬁned for the initial
analysis (entire cortex analysis, Monte Carlo Sim-
ulation and automated clustering). In patients, we
found a signiﬁcant cortical thinning with the AA/AG
genotype compared to controls with the same geno-
type covering smaller parts of the left inferior and
middle temporal region and the right inferior tem-
poral, fusiform and lateral occipital cortex. No signiﬁ-
cant effects were detected for cortical folding.
Discussion
The investigated NCAN variant is one of the few
genetic risk factors for major psychoses (BD, schizo-
phrenia) that has received genome-wide support and
robust evidence for replication in follow-up studies.
To the best of our knowledge, the present study is
the ﬁrst to characterize the impact of this variant on
the cortex structure in humans.
Effect of NCAN variation on occipital and frontal
cortical folding
Our main ﬁnding was that cortical folding in associ-
ation with NCAN risk status was signiﬁcantly altered
in parts of the primary and secondary visual areas
(V1, V2) of the right occipital lobe in patients with
schizophrenia, but not in the matched controls. Both
V1 and V2 are related to early visual processing and
deﬁcits for these areas have been reported for schizo-
phrenia (Butler & Javitt, 2005). Disturbed cortical inte-
gration of visual and other sensory inputs is thought to
be involved in cognitive disruption in schizophrenia,
as suggested by current bottom-up models (Javitt,
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Fig. 1. Effect of the neocan (NCAN) risk status on cortical folding in patients with schizophrenia. Statistical maps show the
identiﬁed anatomical clusters (coloured in blue) encompassing regions in (a) the left prefrontal and (b) the right lateral
occipital cortex. Bar diagrams illustrate the folding differences between risk allele carriers (AA+AG) compared to non-risk
allele carriers (GG) of the single nucleotide polymorphism (SNP) rs1064395. Mean cortical folding values extracted from the
anatomical clusters between risk and non-risk carriers. Error bars indicate 95% conﬁdence interval.
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2009). Although the visual cortex in schizophrenia
seems to be relatively free from reductions in grey
matter volume (Honea et al. 2005), several independent
studies of schizophrenia have found alterations of oc-
cipital cortical folding (White et al. 2003; Narr et al.
2004; Schultz et al. 2010a, 2013). Hence, the observed
association between the NCAN risk variant and dis-
turbed occipital cortex folding suggests a role for
NCAN in visual processing. Future studies are war-
ranted to validate and further explore this potential
function of NCAN.
Second, we found a strong statistical trend in the left
hemisphere for altered dorsolateral prefrontal cortical
folding in patients with NCAN risk. Prefrontal dys-
function is thought to be a major constituent of altered
cognitive control in schizophrenia (Minzenberg et al.
2009), with crucial functions in higher-level gating
and top-down processing (Miller, 2000). Thus, the
joint ﬁnding of fronto-occipital cortical folding altera-
tions provides indirect support for an integrative
model of both higher-order and early sensory proces-
sing deﬁcits in the cortex of schizophrenia patients
(Silbersweig & Stern, 1996; Adcock et al. 2009;
Hugdhal, 2009; Hahn et al. 2010; Neuhaus et al. 2011;
Waters et al. 2012). Moreover, our ﬁndings might
reﬂect a potential pathomechanism for an additive
disruption of top-down and bottom-up cortical pro-
cessing associated with schizophrenia.
Third, we found a signiﬁcantly stronger effect of the
genotype on right superior parietal cortical folding in
patients compared to controls in the direction of higher
cortical folding in risk carriers. Hence, this ﬁnding sup-
ports the observed effects of the NCAN risk genotype
on cortical folding in patients. The superior parietal
cortex is known as a crucial structure for the reorgan-
ization of information during working memory proces-
sing (Koenigs et al. 2009). Disturbed working memory
is one of the major pathophysiological features in
schizophrenia (Forbes et al. 2009). Both prefrontal and
superior parietal dysfunction constitute important ele-
ments in the context of disturbed cognitive control and
associated altered working memory deﬁcits in schizo-
phrenia (Minzenberg et al. 2009). Thus, our ﬁnding of
a signiﬁcant genotype×diagnosis interaction strength-
ens the view that NCAN might be involved in altered
higher-order cognitive functioning in schizophrenia.
In view of our previous result that NCAN variation
is also a common risk factor for BD (Cichon et al.
2011), it is of note that top-down cognitive dysfunction
(Hill et al. 2008; Reichenberg et al. 2009) and visual
processing deﬁcits (Green et al. 1994; Yeap et al. 2009)
are thought to be neurobiological features of both
major psychoses. This observation might lead to the
conclusion that speciﬁc common cognitive features in
schizophrenia and BD are based on overlapping
genetic risk variants such as NCAN. In view of the
recent aetiological discussions about the psychosis
spectrum, we are of the opinion that only a convergent
integration of genetic, cognitive and neuroimaging fea-
tures can shed further light on this important issue.
Cortical folding as an intermediate phenotype
associated with NCAN variation in schizophrenia
An important aspect of our study is that the NCAN risk
variant demonstrated an association with cortical fold-
ing but not with cortical thickness. This observation
provides further support for accumulating evidence
that speciﬁc neuroimaging features can be pheno-
typically and genetically independent (Panizzon et al.
2009; Winkler et al. 2010). Our data suggest that
NCAN might be speciﬁcally related to cortical folding
rather than cortical thickness. This provides the ﬁrst
genetic evidence for a speciﬁc underpinning of
localized cortical folding aberrations in schizophrenia.
As suggested by the spatiotemporal gene ex-
pression patterns in mice and humans (Cichon et al.
2011), along with the functions of NCAN known to
date (Frischknecht & Seidenbecher, 2008; Karetko &
Skangiel-Kramska, 2009; Miró et al. 2012), the common
genetic variant in NCAN most probably exerts its
disease-relevant effect on cortex structure when
major folding processes (gyriﬁcation) take place
(White et al. 2003). After the cortical folding pattern
has been established, it is largely maintained during
life (Armstrong et al. 1991). In line with this, mechan-
ical models of brain development in primates indicate
that folding is driven by the formation of cortico-
cortical connections (Hilgetag & Barbas, 2006), and
further animal experiments have demonstrated that
early disruption of white matter connections are
related to focal hypergyria (Goldman-Rakic, 1980).
This view is also supported by a recent study by
Dauvermann et al. (2012), who analysed prefrontal
gyriﬁcation together with functional connectivity.
Overall, our results, in conjunction with prior knowl-
edge, indicate that increased prefrontal gyriﬁcation
might be related to increased short-range and reduced
long-range connectivity. Thus, our ﬁnding that genetic
variation in NCAN is speciﬁcally associated with
altered cortical folding, a neurodevelopmental cortical
marker, ﬁts well with previous molecular and neuro-
imaging studies.
Based on current knowledge, the question of how
NCAN (encoding neurocan) contributes precisely to
these neurodevelopmental processes at the molecular
level cannot be answered deﬁnitively. In humans,
NCAN is expressed in many cortical and subcortical
regions (see BrainSpan: Atlas of the Developing
Human Brain; www.brainspan.org). The expression
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in the cortex peaks during development starts to fall
after birth, and decreases continually until the end of
life (Human Brain Transcriptome (transcriptome data
and associated metadata for the developing and
adult human brain, www.hbatlas.org); Johnson et al.
2009; Kang et al. 2011). Therefore, high NCAN ex-
pression levels coincide with the maturation of folding
and connectivity patterns. This, and its molecular prop-
erties as an ECM molecule, enable neurocan to par-
ticipate in the modulation of cell adhesion and
migration processes during corticogenesis. As cortical
folding, in addition to the mechanical properties of axo-
nal ﬁbres (‘tension-based hypothesis’), is thought to be
caused by synergistic effects of cell proliferation and
differentiation (‘grey matter hypothesis’) (Zilles et al.
2013), it seems likely that NCAN proteins are involved
in cortical folding. The common genetic variant (SNP
rs1064395) that we have analysed in the present study
is a risk factor for schizophrenia and also for BD, but
has not yet been characterized at the molecular genetic
level. Our imaging genetics study provides the ﬁrst evi-
dence for a potential effect of the risk variant (A allele)
on cortex structure. How the variant or another variant
in linkage disequilibrium contributes exactly to an
aberrant folding in the occipital and frontal regions
remains to be elucidated in further follow-up studies.
Limitations
Cortical folding is regarded as an important ana-
tomical feature in schizophrenia (Mangin et al. 2010).
In the present study we demonstrated the inﬂuence
of NCAN on frontal and occipital cortical folding
using an entire cortex approach. However, it cannot
be excluded that other regions might be affected
using region-of-interest (ROI) approaches. Thus, fur-
ther studies with independent samples are needed to
explore the role of NCAN in disease architecture.
Regarding the comparison of cortical folding be-
tween patients and controls, it might be of relevance
that the numbers of risk allele carriers in both diagnos-
tic groups were equal. This might explain why we
could not detect any folding differences between the
diagnostic groups as we demonstrated that the
NCAN SNP inﬂuences cortical folding in patients.
One further limitation is that, because of the lack
of longitudinal data, we cannot provide information
about differences with regard to psychosis outcome,
which might be inﬂuenced by the risk variant in as-
sociation with the inﬂuence on cortical folding. Thus,
longitudinal studies on this issue are warranted.
Conclusions
This is the ﬁrst study to describe a potential neuro-
anatomical pathomechanism driven by a NCAN risk
variant in schizophrenia patients. In particular, we
used a systematic imaging genetics approach across
both hemispheres and identiﬁed that the risk allele or
alleles in linkage disequilibrium with it inﬂuence the
folding of the occipital and prefrontal lobe in patients
but not in controls. This ﬁnding indicates a potential
role for NCAN in higher-order cognitive functioning
and early visual processing. Both major cognitive pro-
cesses are known to be disturbed in schizophrenia.
Our study also provides evidence for a speciﬁc genetic
underpinning of localized cortical folding aberrations
in schizophrenia. This work is a good starting point
for future studies, which should further investigate
the suggested functional aspects along with the poss-
ible role of NCAN variation in brains of patients with
BD. In general, we conclude that it might be beneﬁcial
to assess cortical folding as an additional intermediate
phenotype in future studies of the cortex structure.
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